ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

Caplan: NEJM Should Go “The Extra Moral Mile”

January 9, 2009

Gates, Bloomberg Fund Project To Reduce Tobacco Use.

July 25, 2008

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Centers Subcommittee Kills Guidelines Proposal, Suggest Formula Ceiling On Core Grants

January 6, 1978